Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as against Rs 94.86 crore during the previous quarter ended June 2023. Sales rose 55.55% to Rs 715.59 crore in the quarter ended June 2024 as against Rs 460.03 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 715.59 | 460.03 | 56 |
| OPM % | 34.93 | 36.90 | - |
| PBDT | 191.26 | 153.38 | 25 |
| PBT | 115.32 | 112.49 | 3 |
| NP | 83.18 | 94.86 | -12 |